Table 1.
Baseline clinical data of subjects in the study population
| Characteristic | All subjects (n = 88) | Subjects with ACS (n = 41) | Subjects without ACS (n = 47) | P value | Significance |
|---|---|---|---|---|---|
| Age (mean years ± SD) | 58.7 ± 16.2 | 64.6 ± 14.4 | 53.6 ± 15.7 | 0.44 | NS |
| Male, n (%) | 51 (58) | 25 (61) | 26 (55) | 0.85 | NS |
| Female, n (%) | 37 (42) | 16 (39) | 21 (45) | 0.72 | NS |
| Risk factors | |||||
| Hypertension, n (%) | 45 (51) | 22 (54) | 23 (49) | 0.65 | NS |
| Diabetes, n (%) | 22 (25) | 13 (32) | 9 (19) | 0.18 | NS |
| Smoking, n (%) | 11 (13) | 7 (17) | 4 (9) | 0.23 | NS |
| Renal disease, n (%) | 5 (6) | 3 (7) | 2 (4) | 0.54 | NS |
| Previous interventions, n (PCI/CABG) (%) | 14 (16) | 10 (24) | 4 (9) | 0.05 | S |
| Clinical findings | |||||
| Heart rate (beats/min) (mean ± SD) | 91.6 ± 25.3 | 95.3 ± 32.1 | 88 ± 19.18 | _ | _ |
| Blood pressure (mmHg) (mean ± SD) | |||||
| Diastolic | 84.9 ± 5 | 83.9 ± 20.6 | 84.9 ± 20.4 | _ | _ |
| Systolic | 131.1 ± 26.1 | 134.5 ± 23.6 | 136.1 ± 25.9 | _ | _ |
| Creatinine (mg/dl) (mean ± SD) | 1.4 ± 1.3 | 1.3 ± 1.4 | 1.5 ± 1.8 | _ | _ |
ACS acute coronary syndrome, PCI percutaneous coronary interventions, CABG coronary artery bypass graft, SD standard deviation, NS non-significant, S significant